Mrs Dana Constant, PHARMD | |
3216 E Clear Lake Ave, Springfield, IL 62702-6208 | |
(217) 544-7948 | |
Not Available |
Full Name | Mrs Dana Constant |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3216 E Clear Lake Ave, Springfield, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003217563 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 051.297725 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Dana Constant, PHARMD 3216 E Clear Lake Ave, Springfield, IL 62702-6208 Ph: (217) 544-7948 | Mrs Dana Constant, PHARMD 3216 E Clear Lake Ave, Springfield, IL 62702-6208 Ph: (217) 544-7948 |
News Archive
Inlabtec has published a short article that discusses the benefits gained from use of application specific sterile plastic bags in microbiological food testing.
Clerity Healthcare, a leading provider of end-to-end IT solutions, today announced that it has been selected by GE Healthcare as the exclusive systems integration technical solutions provider for GE Centricity Practice Solution and Centricity Electronic Medical Records (EMR) customers.
Angiotech Pharmaceuticals, Inc. today announced that in connection with its previously announced creditor protection proceedings under the Companies' Creditors Arrangement Act (Canada), it and certain of its subsidiaries filed with the Supreme Court of British Columbia the Second Amended and Restated CCAA Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities.
Six hospitals in Indiana and Alabama have agreed to pay the United States more than $8 million to settle allegations that the health care facilities submitted false claims to Medicare, the Department of Justice announced today.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
› Verified 6 days ago
Gaye Ann Norman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1879 E Sangamon Ave, Springfield, IL 62702 Phone: 217-525-7030 | |
Dr. Lucas B Stoller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 N 1st St, Springfield, IL 62781 Phone: 217-588-6402 | |
Andrea Wilcoxen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 S Koke Mill Rd, Springfield, IL 62711 Phone: 217-726-0979 Fax: 217-726-6114 | |
Harold Lloyd Carter Ii, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3445 Freedom Dr, T-0670, Springfield, IL 62704 Phone: 217-546-5003 | |
Kendra Yociss, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 E Madison St, Springfield, IL 62702 Phone: 217-545-3787 | |
Melinda K Isaacs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 747 N Rutledge St, Springfield, IL 62702 Phone: 217-523-0846 |